Target intelligence / Profile preview

Multiple pathways and enzymes

Molecular classification
Other
01

Overview

The term "Multiple pathways and enzymes" does not refer to a specific, individual biological molecule but is a collective descriptor for therapeutic agents that exert their effects through a broad range of biological targets (Hopkins, 2008, Nature Chemical Biology). This classification is frequently used in pharmacological databases like ChEMBL to categorize drugs with complex, multi-target profiles or those whose primary mechanism involves the simultaneous modulation of various metabolic and signaling networks (Gaulton et al., 2012, Nucleic Acids Research). In the context of drug development, this often relates to the concept of polypharmacology, where a single compound is designed to interact with multiple receptors, enzymes, or transporters to achieve a desired clinical outcome (Guillaume et al., 2014, PubMed). Such an approach is particularly relevant in treating multifactorial diseases like cancer and neurodegenerative disorders, where targeting a single protein may be insufficient to halt disease progression (Knight et al., 2010, Nature Reviews Cancer). However, because this designation lacks a specific molecular structure or a single gene product, it does not possess a defined biological function or a singular role in disease pathology. Drugs associated with this category, such as certain multi-kinase inhibitors, provide therapeutic benefits by disrupting several nodes within a pathological network simultaneously. The lack of specificity inherent in this classification also presents challenges in predicting safety profiles, as interactions with unintended pathways can lead to diverse off-target toxicities (Bowes et al., 2012, Nature Reviews Drug Discovery). Consequently, "Multiple pathways and enzymes" is considered a non-canonical target entry that encompasses a wide variety of distinct biochemical interactions rather than a single therapeutic entity.

Other names
Multi-targetPolypharmacologyNon-specific targetsNetwork pharmacology
02

Mechanism of action

Simultaneous modulation of multiple distinct enzymes, receptors, and signaling pathways to achieve a therapeutic effect.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Off-target toxicityUnpredictable adverse drug reactionsComplex drug-drug interactionsSystemic side effects due to broad biological activity

Beyond the preview

Go deeper on Multiple pathways and enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple pathways and enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call